Research ArticleKDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery
Graphical Abstract
Nanoconstructs may be internalized via several known endocytosis pathways including macropinocytosis, clathrin-mediated, caveolae-mediated pathway or non-specific pathway such as membrane adsorption. Once the nanoconstructs enter the cells, they will be transported through different subcellular compartments. Our studies showed that a clathrin-mediated pathway is predominant during the internalization of Lys–Asp–Glu–Leu (KDEL) peptide gold nanoconstructs and these nanoconstructs are transported to the endoplasmic reticulum via a retrograde pathway mediated by coat protein I (COPI). Overall, the KDEL peptide gold nanoconstructs have potential as a nanoplatform for high efficacy drug delivery.
Section snippets
Preparation of peptide gold nanoconstructs
The structure and conjugation procedures used with the KDEL peptide in the present studies are described in detail in our previous publication.14 Briefly, AuNP-KDEL nanoconstructs were prepared using 1078 molar equivalents of KDEL peptide relative to 20 nm Au NP, as reported previously.14
Cell culture
Sol8 myogenic cells (ATCC, Manassas, VA) were maintained in 5% CO2 at 37 °C in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS (Life Technologies, Grand Island, NY) and penicillin (100
Intracellular trafficking of KDEL peptide gold nanoconstructs
A pulse-chase study was conducted to investigate the intracellular trafficking of KDEL peptide gold (AuNP-KDEL) nanoconstructs. Figure 2 shows the colocalization images of internalized free KDEL peptide and AuNP-delivered KDEL peptides with three cellular compartments: clathrin-coated vesicles, Golgi apparatus and ER. Quantification of colocalization levels of the peptide within each cellular compartment is shown in Figure 3. The analysis shows that both free KDEL peptide and AuNP-KDEL
Discussion
Targeted drug delivery is very important for the efficacy, safety and cost of treatment. One approach is to target the drug by linking specific ligands enabling cellular internalization by a particular cell type via receptor-mediated endocytic pathways. Strategies for targeted drug delivery to subcellular compartments were well reviewed by Rajendran et al.44 Although currently cell-penetrating peptides (CPPs) have shown advantages to facilitate drug delivery into nuclei or mitochondria,45 the
References (51)
- et al.
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Nanomedicine: NBM
(2012) - et al.
Sequence of a 2nd human Kdel receptor
J Mol Biol
(1992) - et al.
A brefeldin-a-like phenotype is induced by the overexpression of a human Erd-2-like protein, Elp-1
Cell
(1992) - et al.
ADP-ribosylation factor is a subunit of the coat of Golgi-derived COP-coated vesicles: a novel role for a GTP-binding protein
Cell
(1991) - et al.
ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway
Cell
(1990) Recycling of proteins between the endoplasmic reticulum and Golgi complex
Curr Opin Cell Biol
(1991)- et al.
Bidirectional transport by distinct populations of COPI-coated vesicles
Cell
(1997) - et al.
pH-dependent binding of KDEL to its receptor in vitro
J Biol Chem
(1993) - et al.
Mechanisms of pH regulation in the regulated secretory pathway
J Biol Chem
(2001) - et al.
Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy
Biomaterials
(2012)
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Biomaterials
Intracellular uptake, transport, and processing of nanostructures in cancer cells
Nanomedicine: NBM
Recent advances in the use of cell-penetrating peptides for medical and biological applications
Adv Drug Deliv Rev
Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin
FEBS Lett
Nanotechnology, big things from a tiny world: a review
Int J u- and e- Service Sci Technol
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
Cancer
Nanocarriers as an emerging platform for cancer therapy
Nat Nanotechnol
Nanomedicine
N Engl J Med
Nanostructured materials in drug and gene delivery: a review of the state of the art
Crit Rev Ther Drug Carrier Syst
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology
Chem Rev
Gold nanoparticles: opportunities and challenges in nanomedicine
Expert Opin Drug Deliv
Gold nanoparticles in biomedical applications: recent advances and perspectives
Chem Soc Rev
Gold nanoparticles in chemical and biological sensing
Chem Rev
Gold nanoparticles: preparation, properties, and applications in bionanotechnology
Nanoscale
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes
Nano Lett
Cited by (42)
New tool for diseases mechanism studies: Endoplasmic reticulum-targeted fluorescent probes
2023, Dyes and PigmentsNon-viral vectors for RNA delivery
2022, Journal of Controlled ReleaseCitation Excerpt :Therefore, it cannot be directly affirmed or denied such relevance. Studies have used ER retention signal motif KDXX or KDEL peptide to modify carriers to realize cargos' transport to ER [187,188]. Our group previously designed ER membrane-decorated hybrid nanoplexes that altered the intracellular pathway of siRNA.
Research on endoplasmic reticulum–targeting fluorescent probes and endoplasmic reticulum stress–mediated nanoanticancer strategies: A review
2021, Colloids and Surfaces B: BiointerfacesNovel strategies of third level (Organelle-specific) drug targeting: An innovative approach of modern therapeutics
2021, Journal of Drug Delivery Science and TechnologyEndoplasmic reticulum-targeting nanomedicines for cancer therapy
2021, Smart Materials in Medicine
No conflict of interest was reported by the authors of this paper.
This work was supported by the University of Idaho Blue Ribbon BANTech initiative.